Matt Angel
Seminars
Thursday 2nd January 2025
Harnessing mRNA Technology to Unlock Cell Engineering Applications Against Solid Tumors
11:15 am
- Introducing Factor’s proprietary platform applying mRNA to in vivo cell engineering therapeutics
- Transforming CAR-T cells in vivo to target solid tumors
- Expressing gene-editing proteins in vivo to turn “cold” tumors into “hot” tumors
